Diagnosing of Acute Tuberculosis

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

November 4, 2020

Study Completion Date

November 4, 2020

Conditions
Tuberculosis
Interventions
DIAGNOSTIC_TEST

analysis of sweat and serum samples for protein markers

collection of blood and sweat samples (with Macroduct Sweat Collecting System) in patients with suspected tuberculosis or proven acute tuberculosis or pulmonary diseases (pneumonia, bronchitis, COPD) and analyzing serum and sweat for protein markers (Early Secretory Antigenic Target (ESAT-6) and Culture Filtrate Protein 10 (CFP-10) and C-reactive protein (CRP) and Amyloid A2 and complement component 1q (C1q)) by mass spectrometry and enzyme-linked immunosorbent assay (ELISA)

Trial Locations (2)

4058

University Hospital Basel, Basel

4132

Hochschule für Lifescience, Muttenz

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03667742 - Diagnosing of Acute Tuberculosis | Biotech Hunter | Biotech Hunter